A tripartite organelle platform links growth factor receptor signaling to mitochondrial metabolism.
Deborah MesaElisa BarbieriAndrea RaimondiStefano FreddiGiorgia MiloroGorana JendrisekGiusi CaldieriMicaela QuartoIrene Schiano LomorielloMaria Grazia MalabarbaArianna BresciFrancesco ManettiFederico VernuccioHind AbdoGiorgio ScitaLetizia LanzettiDario PolliCarlo TacchettiPaolo PintonMassimo BonoraPier Paolo Di FioreSara SigismundPublished in: Nature communications (2024)
One open question in the biology of growth factor receptors is how a quantitative input (i.e., ligand concentration) is decoded by the cell to produce specific response(s). Here, we show that an EGFR endocytic mechanism, non-clathrin endocytosis (NCE), which is activated only at high ligand concentrations and targets receptor to degradation, requires a tripartite organelle platform involving the plasma membrane (PM), endoplasmic reticulum (ER) and mitochondria. At these contact sites, EGFR-dependent, ER-generated Ca 2+ oscillations are sensed by mitochondria, leading to increased metabolism and ATP production. Locally released ATP is required for cortical actin remodeling and EGFR-NCE vesicle fission. The same biochemical circuitry is also needed for an effector function of EGFR, i.e., collective motility. The multiorganelle signaling platform herein described mediates direct communication between EGFR signaling and mitochondrial metabolism, and is predicted to have a broad impact on cell physiology as it is activated by another growth factor receptor, HGFR/MET.
Keyphrases
- growth factor
- endoplasmic reticulum
- small cell lung cancer
- tyrosine kinase
- epidermal growth factor receptor
- high throughput
- oxidative stress
- single cell
- cell death
- air pollution
- reactive oxygen species
- stem cells
- high resolution
- minimally invasive
- working memory
- escherichia coli
- particulate matter
- estrogen receptor
- regulatory t cells
- mass spectrometry
- breast cancer cells
- risk assessment
- mesenchymal stem cells
- type iii